VALN - FCEL INFI and SIOX among pre market gainers

ION Geophysical (NYSE:IO) +45% sees Q3 revenues more than doubling Q/Q Valneva SE (NASDAQ:VALN) +36% after topline results from late-stage VLA2001 COVID-19 trial Adamis Pharmaceuticals (NASDAQ:ADMP) +35% after FDA approves opioid overdose treatment ZIMHI MeiraGTx Holdings (NASDAQ:MGTX) +16%. Oyster Point Pharma (NASDAQ:OYST) +14% FDA approves Oyster Point Pharma's dry eye disease treatment TYRVAYA Xiaobai Maimai (NASDAQ:HX) +9%. InMed Pharmaceuticals (NASDAQ:INM) +10%. Infinity Pharmaceuticals (NASDAQ:INFI) +6%. FuelCell Energy (NASDAQ:FCEL) +6%. Liquidia (NASDAQ:LQDA) +6%. Lipocine (NASDAQ:LPCN) +6% after TLANDO licensing agreement with Antares Pharma Dynavax Technologies (NASDAQ:DVAX) +6% after topline results from late-stage VLA2001 COVID-19 trial Aurora Mobile (NASDAQ:JG) +5%. Venus Concept (NASDAQ:VERO) +6%. Sio Gene Therapies (NASDAQ:SIOX) +6%. BioHiTech Global (NASDAQ:BHTG) +5%. Progenity (NASDAQ:PROG) +5%.

For further details see:

FCEL, INFI and SIOX among pre market gainers